References and Notes
1a
Crestey F.
Stiebing S.
Legay R.
Collot V.
Rault S.
Tetrahedron
2007,
63:
419
1b
Collot V.
Bovy PR.
Rault S.
Tetrahedron
Lett.
2000,
41:
9053
1c
Collot V.
Dallemagne P.
Bovy PR.
Rault S.
Tetrahedron
1999,
55:
6917
2a
Crestey F.
Collot V.
Stiebing S.
Lohier J.-F.
Sopkova-de Oliveira Santos J.
Rault S.
Tetrahedron Lett.
2007,
48:
2457
2b
Crestey F.
Collot V.
Stiebing S.
Rault S.
Synthesis
2006,
3506
2c
Crestey F.
Collot V.
Stiebing S.
Rault S.
Tetrahedron
2006,
62:
7772
2d
Witulski B.
Azcon JR.
Alayrac C.
Arnautu A.
Collot V.
Rault S.
Synthesis
2005,
771
2e
Arnautu A.
Collot V.
Calvo Ros J.
Alayrac C.
Witulski B.
Rault S.
Tetrahedron Lett.
2002,
43:
2695
2f
Collot V.
Varlet D.
Rault S.
Tetrahedron
Lett.
2000,
41:
4363
3a
Herradura PS.
Pendola KA.
Guy RK.
Org.
Lett.
2000,
2:
2019
3b
Chan DMT.
Monaco KL.
Wang R.-P.
Winters MP.
Tetrahedron
Lett.
1998,
39:
2933
3c
Lam PYS.
Clark CG.
Saubern S.
Adams J.
Winters MP.
Chan DMT.
Combs A.
Tetrahedron Lett.
1998,
39:
2941
4a
Kotha S.
Lahiri K.
Kashinath D.
Tetrahedron
2002,
58:
9633
4b
Suzuki A.
J.
Organomet. Chem.
1999,
576:
147
4c
Miyaura N.
Suzuki A.
Chem. Rev.
1995,
95:
2457
5
Webb KS.
Levy D.
Tetrahedron Lett.
1995,
36:
5117
6
Salzbrunn S.
Simon J.
Prakash GKS.
Petasis NA.
Olah GA.
Synlett
2000,
1485
7
Thiebes C.
Prakash GKS.
Petasis NA.
Olah GA.
Synlett
1998,
141
8
Urawa Y.
Ogura K.
Tetrahedron Lett.
2002,
44:
271
9
Petasis NA.
Goodman A.
Zavialov IA.
Tetrahedron
1997,
53:
16463
10a
Hall DG.
Boronic
Acids - Preparation and Applications in Organic Synthesis
Wiley-VCH;
Weinheim:
2005.
10b
Chincilla R.
Najera C.
Yus M.
Chem.
Rev.
2004,
104:
2667
11 For a recent review on heterocyclic
boronic acids, see: Tyrell E.
Brookes P.
Synthesis
2003,
469
For the main references at this
time to obtain 4-indazolyl-boronic acids and esters, see:
12a
Folkes AJ.
Ahmadi K.
Alderton WK.
Alix S.
Baker ST.
Box G.
Chuckowree IS.
Clarke PA.
Depledge P.
Eccles SA.
Friedman LS.
Hayes A.
Hancox TC.
Kugendradas A.
Lensun L.
Moore P.
Olivero AG.
Pang J.
Patel S.
Pergl-Wilson GH.
Raynaud FI.
Robson A.
Saghir N.
Salphati L.
Sohal S.
Ultsch MH.
Valenti M.
Wallweber HJA.
Wan NC.
Wiesmann C.
Workman P.
Zhyvoloup A.
Zvelebil MJ.
Shuttleworth S.
J. Med. Chem.
2008,
51:
5522
12b Chuckowree I, Folkes A, Hancox T, and Shuttleworth S. inventors; WO 07129161.
; Chem. Abstr. 2007, 147, 541901
12c Shuttleworth SJ, Folkes
AJ, Chuckowree IS, Wan NC, Hancox TC, Baker SJ, Sohal S, and Latif MA. inventors; WO 06046040.
; Chem. Abstr. 2006, 144, 450724
12d Yoon T, Yuan J, Lee K, Maynard GD, and Liu N. inventors; WO 06004589.
; Chem. Abstr. 2006, 144, 128985
12e Lee K, Yuan J, Maynard GD, Hutchison A, and Mitchell S. inventors; WO 05110991.
; Chem. Abstr. 2005, 144, 6683
For the main references at this
time to obtain 5-indazolyl-boronic acids and esters, see:
13a Alberti MJ, and Jung DK. inventors; WO 06044753.
; Chem. Abstr. 2006,
144, 432843
13b Yamashita DS, Lin H, and Wang W. inventors; WO 05085227.
; Chem. Abstr. 2005, 143, 306183
13c Hagihara M, Komori K.-I, Sunamoto H, Nishida H, Matsugi T, Nakajima T, Hatano M, Kido K, and Hara H. inventors; WO 05035506.
; Chem. Abstr. 2005, 142, 411353
13d McAlpine IJ, Deal JG, Johnson MC, Kephart
SE, Park JY, Romines WH, and Tikhe JG. inventors; US 05090529.
; Chem. Abstr. 2005, 142, 430272
13e Shoda M, and Kuriyama H. inventors; WO 03070686.
; Chem. Abstr. 2003, 139, 214465
For the main references at this
time to obtain 6-indazolyl-boronic acids and esters, see:
14a Frazee JS, Hammond M, Kano K, Manns S, Nakamura H, Thompson SK, and Washburn DG. inventors; WO 06063167.
; Chem. Abstr. 2006, 145, 62865
14b Lu T, Thieu TV, Player MR, Lee
Y.-K, Parks DJ, Markotan TP, Pan W, and Milkiewicz
KL. inventors; WO 06047415.
; Chem. Abstr. 2006, 144, 450703
14c Bamborough P, Campos SA, Patel VK, Swanson S, and Walker AL. inventors; WO 05073189.
; Chem. Abstr. 2005, 143, 211906
For the main references at this
time about 7-indazolyl-boronic acids and esters, see:
15a Shipps GW, Cheng CC, Huang X, Fischmann TO, Duca JS, Richards M, Zeng H, Sun B, Reddy PA, Wong TT, Tadikonda PK, Siddiqui MA, Labroli MM, Poker C, and Guzi TJ. inventors; WO 08054702.
; Chem. Abstr. 2008, 148, 552346
15b Kelly M, Lee Y, Liu B, Fujimoto T, Freundlich J, Dorsey BD, Flynn GA, and Husain A. inventors; US 06270686.
; Chem. Abstr. 2006, 146, 7835
16
Boulouard M.
Schumann-Bard P.
Butt-Gueulle S.
Lohou E.
Stiebing S.
Collot V.
Rault S.
Bioorg.
Med. Chem. Lett.
2007,
17:
3177
17 Kania RS, Bender SL, Borchardt AJ, Braganza JF, Cripps SJ, Hua Y, Johnson MD, Johnson TO, Luu HT, Palmer CL, Reich SH, Tempczyk-Russell AM, Teng M, Thomas C, Varney MD, and Wallace
MB. inventors; WO 0102369.
; Chem. Abstr. 2001, 134, 100864
18
Gérard A.-L.
Bouillon A.
Mahatsekake C.
Collot V.
Rault S.
Tetrahedron
Lett.
2006,
47:
4665
19
Primas N.
Mahatsekake C.
Bouillon A.
Lancelot J.-C.
Sopkova-de Oliveira Santos J.
Lohier J.-F.
Rault S.
Tetrahedron
2008,
64:
4596
20
Young MB.
Barrow JC.
Glass KL.
Lundell GF.
Newton CL.
Pellicore JM.
Rittle KE.
Selnick HG.
Stauffer KJ.
Vacca JP.
Williams PD.
Bohn D.
Clayton FC.
Cook JJ.
Krueger JA.
Kuo LC.
Lewis SD.
Lucas BJ.
McMasters DR.
Miller-Stein C.
Pietrak BL.
Wallace AA.
White RB.
Wong B.
Yan Y.
Nantermet PG.
J. Med. Chem.
2004,
47:
2995
For example, see:
21a
Jiang Q.
Ryan M.
Zhichkin P.
J.
Org. Chem.
2007,
72:
6618
21b
Lee IYC.
Jung MH.
Lim H.-J.
Lee HW.
Heterocycles
2005,
65:
2505
21c
Organ MG.
Bilokin YV.
Bratovanov S.
J. Org. Chem.
2002,
67:
5176
21d
Schinazi RF.
Prusoff WH.
J.
Org. Chem.
1985,
50:
841
22a
Voisin A.-S.
Bouillon A.
Lancelot J.-C.
Rault S.
Tetrahedron
2005,
61:
1417
22b
Bouillon A.
Lancelot
J.-C.
Sopkova-de Oliveira Santos J.
Collot V.
Bovy
PR.
Rault S.
Tetrahedron
2003,
59:
10043 ; and references cited therein
23
Ishiyama T.
Murata M.
Miyaura N.
J.
Org. Chem.
1995,
60:
7508
24 Reich SH, Bleckman TM, Kephart SE, Romines
WH, and Wallace MB. inventors; WO 01053268.
; Chem. Abstr. 2001, 135: 137505
25
Typical Experimental
Procedure for the Synthesis of Indazolylboronic Esters
To
a solution of 1-(4-bromoindazol-1-yl)ethanone (3a,
1.5 g, 6.3 mmol) in 1,4-dioxane (25 mL) were added successively bis(pinacolato)diboron
(1.8 g, 7.2 mmol, 1.15 equiv) and KOAc (2.8 g, 23.8 mmol, 4.6 equiv)
at r.t. The reaction mixture was degassed under vacuum with argon replacement
three times, then PdCl2
(dppf)-CH2Cl2 (0.3
g, 0.5 mmol, 0.08 equiv) was added, and the degassing procedure
was repeated twice. The reaction was heated under reflux conditions
for 15 min then concentrated in vacuo. After the addition of EtOAc,
the organic layer was washed successively with H2O and
brine, dried over MgSO4, and the solvent evaporated in
vacuo. The crude material was purified by flash column chromatography
on SiO2 (EtOAc-cyclohexane, 1:3) to give 1-[4-(4,4,5,5-tetramethyl[1,3,2]-
dioxaborolan-2-yl)indazol-1-yl)ethanone
(7a); yield 1.8 g (98%); pink
solid; mp 128 ˚C. TLC: R
f
= 0.6
(EtOAc-cyclohexane, 1:4). IR (KBr): 2976, 1713, 1601, 1415,
1349, 1325, 1174, 1151, 932, 756 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 1.42 (s,
12 H), 2.80 (s, 3 H), 7.55 (t, J = 8.3
Hz, 1 H), 7.82 (d, J = 7.1
Hz, 1 ), 8.54 (d, J = 7.1
Hz, 1 H), 8.55 (s, 1 H). ¹³C NMR (100
MHz, CDCl3): δ = 23.1, 25.0, 84.2, 118.3,
128.6, 130.6, 132.0, 138.3, 141.7, 171.1. MS (EI): m/z (%) = 286
(53) [M+], 244 (100), 243
(39), 229 (14), 158 (70), 145 (34), 144 (68), 134 (67). Anal. Calcd
for C15H19BN2O3: C,
62.96; H, 6.69; N, 9.79. Found: C, 62.39; H, 6.48; N, 9.23.
For Suzuki-Miyaura cross-coupling
reactions using K3PO4 as base in DMF, see:
26a
Cailly T.
Fabis F.
Rault S.
Tetrahedron
2006,
62:
5862
26b
Watanabe T.
Miyaura N.
Suzuki A.
Synlett
1992,
207
For Suzuki-Miyaura cross-coupling
reactions using Na2CO3 or Cs2CO3 as
base in dioxane, see:
27a
Song YS.
Lee
Y.-J.
Kim BT.
Heo J.-N.
Tetrahedron
Lett.
2006,
47:
7427
27b
Heo Y.
Song YS.
Kim BT.
Heo J.-N.
Tetrahedron Lett.
2006,
47:
3091
27c
Littke AF.
Fu GC.
Angew.
Chem. Int. Ed.
1999,
37:
3387
28
7-(4-Methoxyphenyl)-1-(tetrahydro-2
H
-pyran-2-yl)-1
H
-indazole (17)
Yield
0.3 g (73%); white solid. TLC: R
f
= 0.1
(EtOAc-cyclohexane, 1:10). IR (KBr): 3428, 2932, 1611,
1497, 1245, 1078, 1032, 824 cm-¹. ¹H
NMR (400 MHz, CDCl3):
δ = 1.37-1.42
(m, 2 H), 1.76-1.78 (m, 1 H), 1.90-1.95 (m,
1
H), 2.56-2.58 (m, 1 H), 2.91-2.96 (m, 1 H), 3.74-3.80
(m, 1 H), 3.91 (s, 3 H), 4.04-4.07 (m, 1 H), 5.00 (dd, J = 12.7, 2.2
Hz, 1 H), 7.02 (dd, J = 7.3,
1.4 Hz, 2 H), 7.18-7.19 (m, 2 H), 7.23-7.26 (m,
2 H), 7.64-7.70 (m, 1 H), 8.12 (s, 1 H). MS (EI): m/z (%) = 308
(22) [M
+
],
224 (100), 209 (26), 192 (2), 182 (8), 154 (7), 85 (8). Anal. Calcd
for C19H20N2O2: C, 74.00;
H, 6.54; N, 9.08. Found: C, 74.30; H, 6.74; N, 9.28.
29
Schumann P.
Collot V.
Hommet Y.
Gsell W.
Dauphin F.
Sopkova J.
McKenzie ET.
Duval D.
Boulouard M.
Rault S.
Bioorg. Med. Chem. Lett.
2001,
11:
1153
30 The use of Oxone® (2KHSO5-KHSO4-K2SO4)
as oxidative reagent in the presence of Na2CO3 in
a mixture of H2O-acetone (1:1) at 0 ˚C
led to the desired compounds but in lower yields.